Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, H&R GmbH KGaA's Enterprise Value is €321 Mil.
H&R GmbH KGaA's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was €-12 Mil. Therefore, H&R GmbH KGaA's EV-to-EBIT ratio for today is -27.59.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, H&R GmbH KGaA's Enterprise Value is €321 Mil.
H&R GmbH KGaA's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was €43 Mil. Therefore, H&R GmbH KGaA's EV-to-EBITDA ratio for today is 7.40.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, H&R GmbH KGaA's Enterprise Value is €321 Mil.
H&R GmbH KGaA's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was €1,196 Mil. Therefore, H&R GmbH KGaA's EV-to-Revenue ratio for today is 0.27.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, H&R GmbH KGaA's Enterprise Value is €321 Mil.
H&R GmbH KGaA's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was €65 Mil. Therefore, H&R GmbH KGaA's EV-to-FCF ratio for today is 4.95.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
H&R GmbH KGaA (WBO:2HRA) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
H&R GmbH KGaA's current Enterprise Value is €321 Mil.
H&R GmbH KGaA's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-12 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
H&R GmbH KGaA's current Enterprise Value is €321 Mil.
H&R GmbH KGaA's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €43 Mil.
H&R GmbH KGaA's current Enterprise Value is €321 Mil.
H&R GmbH KGaA's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €1,196 Mil.
H&R GmbH KGaA's current Enterprise Value is €321 Mil.
H&R GmbH KGaA's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €125 Mil.
H&R GmbH KGaA's current Enterprise Value is €321 Mil.
H&R GmbH KGaA's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €65 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
H&R GmbH KGaA Enterprise Value Related Terms
H&R GmbH KGaA Enterprise Value Historical Data
* Premium members only.
The historical data trend for H&R GmbH KGaA's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WBO:2HRA vs LIN, SHW, ECL: Enterprise Value Comparison
For the Specialty Chemicals subindustry, H&R GmbH KGaA's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
H&R GmbH KGaA Enterprise Value vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, H&R GmbH KGaA's Enterprise Value distribution charts can be found below:
* The bar in red indicates where H&R GmbH KGaA's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
H&R GmbH KGaA's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
H&R GmbH KGaA (WBO:2HRA) has a Enterprise Value of €321 Mil as of Jul. 25, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on H&R GmbH KGaA and its competitors.
Is H&R GmbH KGaA's Enterprise Value too high?
H&R GmbH KGaA's current Enterprise Value is €321 Mil. Overall, H&R GmbH KGaA has a GF Score™ of 40/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does H&R GmbH KGaA's Enterprise Value compare to LIN and SHW?
H&R GmbH KGaA's Enterprise Value of €321 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Chemicals company?
A good Enterprise Value depends on the Chemicals industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on H&R GmbH KGaA and its competitors. H&R GmbH KGaA's current Enterprise Value is €321 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is H&R GmbH KGaA stock overvalued right now?
Based on GuruFocus' analysis, H&R GmbH KGaA (WBO:2HRA) is currently considered Significantly Overvalued. The stock's GF Value™ is €4.25, compared to a current price of €6.46 — trading 52% above its estimated fair value. The current Enterprise Value is €321 Mil. H&R GmbH KGaA's overall GF Score™ is 40/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For H&R GmbH KGaA (WBO:2HRA), the current Enterprise Value is €321 Mil as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is H&R GmbH KGaA (WBO:2HRA) Overvalued in 2026?
Based on GuruFocus' analysis, H&R GmbH KGaA stock appears to be overvalued.
The current stock price of €6.46 is trading 52% above its estimated GF Value™ of €4.25.
GuruFocus considers H&R GmbH KGaA to be Significantly Overvalued.
Key valuation signals for WBO:2HRA:
Enterprise Value: €321 Mil
GF Value™: €4.25 vs. price of €6.46 (52% above fair value)
No single metric tells the full story. See the WBO:2HRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
H&R GmbH & Co KGaA is a manufacturer of chemical-pharmaceutical specialty products. The company organizes its operating activities into two business divisions: Chemical-Pharmaceutical Raw Materials and Plastics. It also has three business segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment produces specialty products from crude oil in the two domestic refineries (Hamburg-Neuhof and Salzbergen). Its ChemPharm Sales segment encompasses the production sites abroad as well as international sales activities. The company's Plastics segment manufactures high-precision plastic parts along with the associated tools and molds. The company derives a majority of its revenue from the ChemPharm Refining segment. Geographically, it derives key revenue from Germany.
40GF Score
Get the complete analysis for WBO:2HRA
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:2HRA has been successfully added to your 
